We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+19.64%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.47B
AUM Growth
+$251M
Cap. Flow
-$37.4M
Cap. Flow %
-1.51%
Top 10 Hldgs %
47.29%
Holding
93
New
13
Increased
28
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
WRLD icon
World Acceptance Corp
WRLD
+$14.4M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$12.1M
3
AKBA icon
Akebia Therapeutics
AKBA
+$11.4M
4
XELA
Exela Technologies, Inc. Common Stock
XELA
+$10.2M
5
ZVO
Zovio Inc. Common Stock
ZVO
+$9.12M

Top Sells

Rank Stock Value
1
SIGA icon
SIGA Technologies
SIGA
+$23M
2
CGNT
Cogentix Medical, Inc.
CGNT
+$14M
3
AGS
PlayAGS
AGS
+$9.28M
4
QURE icon
uniQure
QURE
+$2.67M
5
THC icon
Tenet Healthcare
THC
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 18.02%
2 Financials 8.26%
3 Industrials 6.87%
4 Technology 5.75%
5 Consumer Discretionary 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
51
Iovance Biotherapeutics
IOVA
$2.87B
$10.6M 0.43%
+825,000
New +$12.1M
FTD
52
DELISTED
FTD Companies, Inc. Common Stock
FTD
$10.2M 0.41%
2,198,663
+46,383
+2% +$260K
DHX icon
53
DHI Group
DHX
$173M
$9.69M 0.39%
4,121,092
+1,689,427
+69% +$3.42M
ELVT
54
DELISTED
Elevate Credit, Inc.
ELVT
$9.63M 0.39%
1,138,326
– –
GLMD icon
55
Galmed Pharmaceuticals
GLMD
$4.97M
$8.82M 0.36%
4,117
+2,402
+140% +$3.48M
AKBA icon
56
CALL
Akebia Therapeutics
AKBA
$252M
$8.49M 0.34%
851,000
+551,000
+184% +$5.52M
CCXI
57
DELISTED
ChemoCentryx, Inc.
CCXI
$8.1M 0.33%
615,173
+14,685
+2% +$176K
TLYS icon
58
Tilly's
TLYS
$128M
$7.76M 0.31%
512,103
– –
F icon
59
PUT
Ford
F
$55.7B
$7.75M 0.31%
+700,000
New +$8.01M
GAIA icon
60
Gaia
GAIA
$48.4M
$7.05M 0.29%
347,996
-52,800
-13% -$931K
RRR icon
61
PUT
Red Rock Resorts
RRR
$3.62B
$6.7M 0.27%
200,000
-125,000
-38% -$4.06M
TAX
62
DELISTED
Liberty Tax, Inc. Class A
TAX
$6.53M 0.26%
808,239
+129,202
+19% +$1.28M
EMMS
63
DELISTED
Emmis Communications Corp
EMMS
$5.78M 0.23%
1,162,900
– –
ACER
64
DELISTED
Acer Therapeutics Inc
ACER
$5.41M 0.22%
250,252
– –
NATR icon
65
Nature's Sunshine
NATR
$288M
$5.39M 0.22%
576,602
– –
RRTS
66
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$5.33M 0.22%
+102,020
New +$5.68M
CUE icon
67
Cue Biopharma
CUE
$114M
$5.02M 0.2%
+14,119
New +$5.61M
ASCMA
68
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$4.62M 0.19%
1,644,260
+502,075
+44% +$1.41M
SHOS
69
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$4.57M 0.19%
2,176,251
– –
APEN
70
DELISTED
Apollo Endosurgery, Inc.
APEN
$4.54M 0.18%
+649,941
New +$4.04M
JYNT icon
71
The Joint Corp
JYNT
$119M
$4.38M 0.18%
+534,822
New +$3.98M
SSKN
72
DELISTED
Strata Skin Sciences
SSKN
$4.26M 0.17%
+207,858
New +$3.39M
RFL icon
73
Rafael Holdings
RFL
$107M
$4.05M 0.16%
+447,267
New +$3.53M
SRL icon
74
Scully Royalty
SRL
$87.1M
$3.99M 0.16%
674,555
+144,816
+27% +$902K
DVD
75
DELISTED
Dover Motorsports
DVD
$3.88M 0.16%
1,725,789
– –
1 2
3
4

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Nantahala Capital Management held 93 positions worth $2.47B, up 11% from $2.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Nantahala Capital Management's Q2 2018 filing shows 13 new, 28 increased, 15 reduced and 4 closed positions. Its largest new stake was Iovance Biotherapeutics: 825,000 shares worth $10.6M. The largest sale was SIGA Technologies, an estimated $23M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Nantahala Capital Management's largest Q2 2018 buy was Iovance Biotherapeutics: 825,000 shares worth $10.6M.
  • Nantahala Capital Management added most to World Acceptance Corp in Q2 2018, an estimated $14.4M increase.
  • Nantahala Capital Management's biggest Q2 2018 reduction was SIGA Technologies, cutting an estimated $23M.
  • Nantahala Capital Management fully exited Cogentix Medical, Inc. in Q2 2018, selling an estimated $14M.
  • Nantahala Capital Management's ten largest holdings make up 47% of its $2.47B portfolio in Q2 2018.
  • Nantahala Capital Management opened 13 new positions and closed 4 in Q2 2018.
  • Nantahala Capital Management's portfolio value rose 11% quarter-over-quarter to $2.47B.

Based on Nantahala Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.